This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Health Revenue Assurance Holdings, Inc. Reports Financial Results For The 4th Quarter And Year-end 2012; Company To Hold Earnings Conference Call April 2, 2013

Stocks in this article: HRAA

Plantation, April 1, 2013 (GLOBE NEWSWIRE) -- Health Revenue Assurance Holdings, Inc. (OTCBB: HRAA), a provider of technology and revenue integrity solutions for healthcare organizations, announced its financial results for the fourth quarter and full year ended December 31, 2012.

Fourth Quarter and Full Year 2012 Highlights:

  • Total quarterly revenue of $2,187,237 increased 421% as compared to $419,495 for the prior year's fourth quarter;
  • Total yearly revenue of $5,806,848 increased 305% versus revenues of $1,432,773 for the full year of 2011;
  • Cash balance of $893,458 at the end of 2012 as compared to a cash balance of $198,500 in the same period of 2011;

Andrea Clark, HRAA's Chairman, CEO and Founder stated, "The fourth quarter was another successful quarter for HRAA as we continue to deliver strong results reflected by the record revenues we have achieved. The quarter was also marked with a significant milestone for the Company as we recorded the first sale of our ICD-Visualizerä software solution. This revolutionary product has helped our client to mitigate their risk in preparation for the upcoming mandated switch from ICD-9 to ICD-10 in October of 2014.

Clark concluded, "In the fourth quarter, we also introduced our second software solution package, Readmissions Visualizerä. This product provides hospitals worldwide with the ability to view current inpatient and historical readmissions information through an intuitive web interface for the purpose of decreasing readmissions within the healthcare system. The demand for readmission analysis is rapidly growing as seen under the Affordable Care Act as 2,217 hospitals were penalized under this program and 307 hospitals were ordered to pay 1% of the Medicare reimbursement for 2012. As we continue to execute on our business plan, we look forward to providing best-of-breed software solutions as well as auditing, consulting and coding services that help maintain revenue integrity throughout the healthcare system."

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,387.21 -291.49 -1.65%
S&P 500 2,029.55 -27.54 -1.34%
NASDAQ 4,681.4970 -90.2660 -1.89%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs